Option Investor
Newsletter

ADDITIONAL PLAY FOR MARCH RECOMMENDED LIST

HAVING TROUBLE PRINTING?
Printer friendly version

We are adding an additional position to our MARCH RECOMMENDED LIST:

We are recommending put writes on the following issue:

CONR - Conor Medsystems, Inc.,
a development stage company, engages in the development and commercialization of controlled vascular drug delivery technologies principally in the United States. Through its proprietary design, it controls drug release kinetics, or the rate of drug release over time. The company focuses on the development of COSTAR stent, a cobalt chromium paclitaxel eluting stent, for the treatment of restenosis, or the re-narrowing of the inner channel of the artery following balloon angioplasty. Stents are tubular mesh devices consisting of interconnected metal struts that are inserted inside an artery to act as scaffolding, propping open a narrowed blood vessel.

We are recommending the following specific put write:

CONR $23.60
SELL CONR MAR SYM: QAP-OD
Target Price $30.00 20 Put
Potential Profit(10 x = $300.00
Initial Margin $5,020 10 (contracts)
Return on Investment 5.98%
Cost Basis in Stock = $19.70
Days to Expiration = 24
Stock goes on Watch List Price at: $22.00
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $20.00


Option Writers Newsletter Archives